Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05536440 · ClinicalTrials.gov registry record · Phase 1
A Study to Learn About Study Medicine Called PF-07261271 in Healthy People
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT05536440 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 35 participants.
The verdict
NCT05536440, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to learn about the safety and effects of the study medicine PF-07261271 for the potential treatment of Inflammatory Bowel Disease.
Interventions
- DRUG Placebo
- DRUG PF-07261271
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2022-10-17 |
| Est. Completion | 2024-02-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05536440
The ClinicalTrials.gov registry entry for NCT05536440 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05536440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05536440 about?
NCT05536440 is a clinical study titled "A Study to Learn About Study Medicine Called PF-07261271 in Healthy People". The purpose of this clinical trial is to learn about the safety and effects of the study medicine PF-07261271 for the potential treatment of Inflammatory Bowel Disease.
What is the current status of trial NCT05536440?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2022-10-17. Estimated completion is 2024-02-29.
What interventions are being tested in trial NCT05536440?
The interventions under investigation include: Placebo (DRUG), PF-07261271 (DRUG).
Who is sponsoring clinical trial NCT05536440?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.